| Tag | Content |
|---|
EnhancerAtlas ID | HS150-02265 |
Organism | Homo sapiens |
Tissue/cell | NT2-D1 |
Coordinate | chr11:63215560-63216650 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF2 | MA0051.1 | chr11:63215912-63215930 | TGATAGGTTTCACTATCC | - | 6.14 | | LHX2 | MA0700.1 | chr11:63215989-63215999 | ACTAATTAAC | + | 6.02 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr11 | 63215772 | 63216200 | | chr11 | 63215650 | 63215942 | | chr11 | 63216004 | 63216510 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I063448 | chr11 | 63215857 | 63216883 |
|
Enhancer Sequence | ACAAGCCCTG ATGAGCCTTG CCCACACCCC TTTCCAAGCC CAGCCTTGTA GAGCAGTAGT 60
CCTAAGTGTG AGCCGCCAAA ACCCTGTTTA ATCAATGATC TATAGGCAGT TATCAGAGTG 120
CTGTTCTCCT GTTGCCCCGT GAAGTGACAG GGCTTTGGGG AATGTGCTCA GGGCTGCAGT 180
GGACCCCTCT CCACAGGGTA CAGAGGTATG GAAGAACAGA GTCCTTGGCA TCTGCATTTG 240
AGCAAGACAC AGAAATTTCT TGTTATATTT CCCTCAGCTG AGATGGTGGT AAAGTTTGCT 300
ACCACTACAG TTGTGTCAGA CTGGGCTCCC TGAGACATTA AAGCTGCCCT CTTGATAGGT 360
TTCACTATCC AGGCAAGTTC TGCCACAGCC ACAAAGTTGG CAGTCTCTGT GCTACATCAA 420
TACCAAAAGA CTAATTAACA CTAAGGAGTT TCTGAGGTTC CACAGATTTC TACTTCCTCC 480
CTGGACTGAA TTCTCACCCC AGCCCTCATA AACAAGACAC GCCTTCTTGC TTCCACTCTT 540
GTAAGCAGAA ATTGAATGTG GGTAATCAAA ACTCAGTGTC TATACCCTGC AGACAACTAC 600
CATCCCAAGG GTGCCAACAA TCAGTTTTGT AAGTTTATCC TACTCACTGA TATATGCTAC 660
TACTCACCTG ATAGTGGGAT TATATGCAGT TGACTCTGCC CCTGCTAGAG AGCCCTGTGG 720
ATGGCACAGC CCTTTGCCAT GGCCCAAATT GTCTCTATTG TGATGCATCA TTGGTCCTTA 780
ATTACCCATT TCCTCTGCTT TTCTCTTGGT CCATTGTGAA TCAGCACTTT ATTTCAGTTT 840
CCTTATTCTA TAAATGTTCA CTCAGTTAAA GCACCGCCAA AGCTGGTTGA AGGGGGAGTC 900
TGTTGAAAAG GGCCACAAAG TCTGCAATAG TAGAAATAAT GGAGATGAAC CCATAGCCAT 960
GGAGTGAGGG AATATCCTCA TCGAGTTGTT TCTAAAATGT GCAAAACAGT GCCTGGCACA 1020
GTGGGAACAC TTGAATGTCA CCACTGTTGT CATTATTTTA TTCCTACTGA CTCTGTTGGC 1080
AAAGCATGTC 1090
|
